Test / Trial definition

Test / Trial means such tests as are prescribed in specifications to be made by the Purchaser or his nominee.
Test / Trial means such tests as are prescribed in specifications to be made by the Purchaser or his nominee, after assembly ex-works before the equipment is installed by the tenderer as well as the tests to be performed before installation and commissioning.
Test / Trial means such tests as are prescribed in specifications of Main engines, Gear Boxes, ASD, Steering system and all other machineries / systems / items installed onboard.

Examples of Test / Trial in a sentence

  • The LCE&S support activities include; but, not limited to:Assist in evolving and supporting the related tasks of logistics management, maintenance, supply support, technical design interface, facilities, technical data, and personnel as it relates to ships production, permanently installed ship mission systems, Post Delivery and Test & Trial (PDT&T) of the LCS Ships.

  • They shall be supplementary to the Frame Agreement and consist of the “Commercial Agreement” itself and its Local Annexes e.g.: - Commercial Agreements concerning the purchase of commercially traded Products & Local Annexes Commercial Agreements for UMTS Products based on 3GPP (Test & Trial) & Local Annexes Both Parties confirm, that they are in possession of the above-mentioned documents of the Frame Agreement.

  • Design and Development of test rig for vibration loosening of bolts then manufacturing and assembly of test rig .Design and development of system components for interchangeability of bolts namely ( M4 , M5 , M6 , &M8) Test & Trial on test rig to develop the loosening characteristics of bolts and derive the decay graphs versus cycles.

  • AWARDSQualifying Test & Trial Dark Green Ribbons1st Blue Ribbon2nd Red Ribbon3rd Yellow Ribbon4th White Ribbon5th Pink RibbonHigh in Trial Blue & White RosetteReserve High in Trial Red & White RosetteMOTELS • Days InnI-71 & SR250, Ashland, OH 44805These motels have been pet friendly.

  • The CGM Programme manager reports that in 2021, the CGM Programme is focused on several key deliverables and milestones for the transition from Programme to Operational mode, including, for example, the completion of the Physical Communication Network rollout, the implementation of an OPDE Service Operational Model and the readiness for Operational Go-Live with all TSOs / RSCs participating in Test / Trial activities.

  • More information on how the interface between public and private funding could operate is given in our first policy briefing on our Eden Model Test & Trial Project with Green Alliance and 3Keel presented to Defra at the end of March (unpublished).

  • Open to AKC-FSS Registered PUMIK, MUDIK and AKC Registered PULIK And for dogs of these breeds with ILP/PAL numbers GREEN GATES FARM6732 Carper Lane Rd.Hillsboro, OH 45133(To be held outdoors, regardless of weather) Test Classes Offered Trial Classes Offered(Sheep only) (Sheep only) Herding Instinct Test Course A StartedHerding Test Course A IntermediatePre-Trial Test Course A Advanced Diane Fletcher, Test & Trial Secretary1811 NW 51s.

  • The Bidder / Firm shall be liable for all expenses pertaining to Test / Trial during Evaluation process.

  • St., Ft. Lauderdale, FL 954.957.5102 dfletcher@coralwave.com ENTRIES CLOSE: Wednesday, October 7, 2015, 5:00 PM PDT Certification: Permission has been granted by The American Kennel Club for the holding of this event under American Kennel Club rules and regulations.James Crowley, Secretary Diane Fletcher, Test & Trial Secretary c/o 5822 66th Ave.

  • Any such loss of function during testing shall be recorded in the Test / Trial Report.

Related to Test / Trial

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase II Trial means a clinical trial of a Licensed Product, designated as a Phase II Trial and the principal purpose of which is to make a preliminary determination that such Licensed Product is safe and active in a patient population for its intended use and is designed to obtain sufficient information about such Licensed Product’s efficacy to permit the design of a Phase III Trial(s), and generally consistent with 21 CFR § 312.21(b). For purposes of this definition, Phase II trial shall specifically exclude expansion cohorts from Phase I Trial(s).

  • Screening Test Technician (STT) means anyone who instructs and assists individuals in the alcohol testing process and operates an ASD.

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase 1 Trial means, with respect to a Product, a human clinical trial that is intended to initially evaluate the safety, metabolism and pharmacokinetics of such Product that would otherwise satisfy the requirements of 21 C.F.R. 312.21(a) or an equivalent clinical trial in a country other than the United States.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Cannabis testing facility means an entity registered by

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Test Issue means any variance or non-conformity of the Services or Deliverables from their requirements as set out in the Call Off Contract;

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Test cycle means a sequence of test points each with a defined speed and torque to be followed by the engine under steady state (WHSC) or transient operating conditions (WHTC).

  • Test Fail has the meaning stated in Section 3.4(a).

  • Home study means the assessment process used for the purpose of determining the ability of an applicant to care for a child in need of foster care placement.

  • Pivotal Clinical Trial means a Phase 3 Clinical Trial, or a Phase 2b Clinical Trial for which the applicable Regulatory Authority has determined that the data generated in such Phase 2b Clinical Trial would be sufficient, depending on its outcome, to support the Regulatory Approval for the applicable Licensed Product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • DNS test Means one non-­‐recursive DNS query sent to a particular “IP address” (via UDP or TCP). If DNSSEC is offered in the queried DNS zone, for a query to be considered answered, the signatures must be positively verified against a corresponding DS record published in the parent zone or, if the parent is not signed, against a statically configured Trust Anchor. The answer to the query must contain the corresponding information from the Registry System, otherwise the query will be considered unanswered. A query with a “DNS resolution RTT” 5 times higher than the corresponding SLR, will be considered unanswered. The possible results to a DNS test are: a number in milliseconds corresponding to the “DNS resolution RTT” or, undefined/unanswered.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).